Actwatch Study Reference Document Uganda Outlet Survey 2015
Total Page:16
File Type:pdf, Size:1020Kb
Evidence for Malaria Medicines Policy ACTwatch Study Reference Document Uganda Outlet Survey 2015 www.ACTwatch.info Copyright © Population Services International (PSI). All rights reserved. Released 29 July 2016 Suggested citation ACTwatch Group and PACE. (2015). ACTwatch Study Reference Document: The Republic of Uganda Outlet Survey 2015. Washington DC: PSI. Contact Dr. Megan Littrell Peter Buyungo ACTwatch Principal Investigator Programme for Aaccessible Communication and Education (PACE) PSI | 1120 19th St NW Suit 600 Uganda Washington DC 20036 Plot # 2, Ibis Vale, Kololo – off Prince Charles Drive | Kampala, Uganda [email protected] [email protected] Acknowledgements ACTwatch is funded by the Bill and Melinda Gates Foundation, UNITAID, and the UK Department for International Development. This study was implemented by Population Services International (PSI). PACE Uganda SEDC (cont.) Fieldwork Team (cont.) Peter Buyungo Dr. Janestic Twikirize Christine Nagaba Henry Kaula Hadijah Mwenyango Denis Okello Doreen Nakimuli Sharlotte Tusasirwe Dianah Komugisha Aloysious Nyombi Dorcas Acheng Ministry of Health Jacob Mutazidwa Edward Kalyesubula Dr. Peter Okui Emmanuel Kiwendo Field Supervisors Godfrey Kusemererwa ACTwatch Team Alex Nduhukire Ibrahim Mandali Andrew Andrada Anne Adikini Jacqueline Namutaaya Erick Auko Bruce Orech Joan Bakanansa Dr. Katie Bates Denis Mitala Jobes Orombi Dr. Desmond Chavasse Jennifer Agwang John Robert Okello Kevin Duff Lawrence Magara Juliet Murungi Keith Esch Mariam Magezi Keneth Nyombi Anna Fulton Monica Dhabangi Linda Tusiime Tracy Tarryn Haslam Moses Okiror Longok Maximilian Koibe Catharine Hurley Olivia Nalwanga Lydia Gift Namuswa Beth Kangwana Marble Katushabe Gloria Kigo Field Quality Controllers Moreen Aliku Dr. Megan Littrell Archileo Kiwanuka Moses Aede Julius Ngigi Bashir Kawalya Musa Kabunga Dr. Kate O’Connell Christine Isunu Norah Nattimba Ricki Orford Jennifer Kobusingye Opio Kizito Stephen Poyer Julia Vera Nashuha Phiona Tumusiime Dr. Justin Rahariniaina Lameck Kawooya Kalule Richard Mugabi Christina Riley Moureen Naamara Rita Ochiba Dr. Andria Rusk Paul Tumuhairwe Samuel Kasoozi Julianna Smith Phionah Kamara Scovia Alinda Rachel Thompson Sarah Akullo Seera Leah Dianah Buke Cynthia Whitman Sira Egweu Stella Mudoola Fieldwork Team Stephen Adiga Socio-Economic Data Center LTD Aaron Kiwanuka Suzan Basalirwa (SEDC) Aisha Nanteza Vicent Otebata Prof. Asingwire Narathius Alice Nahabwe Wilberforce Ssebunya Joseph Kiwanuka Anthony Katende Dr. Denis Muhangi Brian Gilbert Kyomuhendo www.ACTwatch.info Page 1 Table of Contents List of Tables ...................................................................................................................................................... 3 List of Figures ..................................................................................................................................................... 5 Definitions .......................................................................................................................................................... 8 Introduction ..................................................................................................................................................... 10 Summary of Methods and Data Collection ...................................................................................................... 11 Summary of Key Findings ................................................................................................................................. 13 Results Section A: Core Indicators ................................................................................................................... 43 Results Section B: Core Indicators across Urban/Rural Location .................................................................... 61 Results Section C: Core Indicators across Survey Round: 2010, 2011, 2013, 2015 ......................................... 83 Annex 1: ACTwatch Background .................................................................................................................... 109 Annex 2: Country Background ....................................................................................................................... 112 Annex 3: Outlet Survey Methods ................................................................................................................... 118 Annex 4: Sampled Sub-Counties .................................................................................................................... 123 Annex 5: Detailed Sample Description .......................................................................................................... 125 Annex 6: Questionnaire ................................................................................................................................. 127 Annex 7: Antimalarial Reference ................................................................................................................... 149 Annex 8: RDT Reference ................................................................................................................................ 154 Annex 9. Sampling Weights ........................................................................................................................... 156 Annex 10: Indicator Definitions ..................................................................................................................... 158 Annex 11. Adult Equivalent Treatment Dose (AETD) .................................................................................... 166 Annex 12: Antimalarial Volumes.................................................................................................................... 168 www.ACTwatch.info Page 2 List of Tables Results Core Indicators Table S1: Key results, by outlet type - 2015 .................................................................................................................... 13 Table A1: Availability of antimalarials, among all screened outlets, by outlet type ....................................................... 43 Table A2: Availability of antimalarials, among outlets stocking at least one antimalarial, by outlet type ..................... 45 Table A3: Types of quality-assured and Non-Quality Assured ACTs audited in the public and private sector .............. 47 Table A4: Antimalarial market composition ................................................................................................................... 48 Table A5a: Price of tablet formulation antimalarials, by outlet type ............................................................................. 49 Table A5b: Price of pre-packaged antimalarials, by outlet type ..................................................................................... 51 Table A6: Availability of malaria blood testing among antimalarial-stocking outlets*, by outlet type .......................... 52 Table A7: Malaria blood testing market composition .................................................................................................... 53 Table A8: Price of malaria blood testing for adults, by outlet type ................................................................................ 54 Table A9: Antimalarial market share .............................................................................................................................. 55 Table A10: Antimalarial market share across outlet type .............................................................................................. 56 Table A11: Malaria blood testing market share ............................................................................................................. 57 Table A12: Malaria blood testing market share, across outlet type ............................................................................... 58 Table A13: Provider case management knowledge and practices, by outlet type ......................................................... 59 Table A14: Provider antimalarial treatment knowledge and practices, by outlet type ................................................. 60 Results Across Urban/Rural Location Table B1: Availability of antimalarials, among all screened outlets, by outlet type, across urban/rural sub-counties . 61 Table B2: Availability of antimalarials, among all outlets stocking at least one antimalarial, by outlet type, across urban/rural sub-counties ....................................................................................................................................... 65 Table B4: Antimalarial market composition, across urban/rural location ...................................................................... 69 Table B5a: Price of tablet formulation antimalarials, by outlet type, across urban/rural location ................................ 70 Table B5b: Price of pre-packaged antimalarials, by outlet type, across urban/rural location ....................................... 72 Table B6: Availability of malaria blood testing among antimalarial-stocking outlets*, by outlet type, across urban/rural location ............................................................................................................................................... 73 Table B8: Price of malaria blood testing, by outlet type, across urban/rural location ................................................... 74 Table B9.1: Antimalarial market share, urban ...............................................................................................................